SCHEMBL19682896

SCHEMBL19682896

CN(Cc1ccc(/C=C/C(=O)Nc2ccccc2NC(=O)OC(C)(C)C)cc1)CC12CC3CC(CC(C3)C1)C2

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 7/20 0.66
▸ HDAC1 Q13547 6/20 0.66
▸ HDAC3 O15379 5/20 0.66
▸ HDAC5 Q9UQL6 4/20 0.66
▸ HDAC2 Q92769 3/20 0.66
▸ HDAC4 P56524 3/20 0.66
▸ HDAC10 Q969S8 2/20 0.66
▸ HDAC8 Q9BY41 2/20 0.66
▸ KDM1A O60341 2/20 0.47
▸ ACHE P22303 5/20 0.44
▸ BCHE P06276 4/20 0.44
▸ MAOA P21397 1/20 0.43
▸ MAOB P27338 1/20 0.43
▸ P2RX7 Q99572 1/20 0.43
▸ HDAC7 Q8WUI4 1/20 0.41
▸ RARB P10826 1/20 0.39
▸ TRPV1 Q8NER1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17478445 0.87 HDAC6 (0.73) HDAC6HDAC1HDAC3HDAC5HDAC2
SCHEMBL17478446 0.87 HDAC6 (0.73) HDAC6HDAC1HDAC3HDAC5HDAC2
SCHEMBL17478531 0.85 HDAC1 (0.71) HDAC6HDAC1HDAC3HDAC5HDAC2
SCHEMBL19683022 0.85 HDAC1 (0.71) HDAC6HDAC1HDAC3HDAC5HDAC2
SCHEMBL17478501 0.85 HDAC1 (0.71) HDAC6HDAC1HDAC3HDAC5HDAC2
SCHEMBL19666050 0.85 HDAC1 (0.71) HDAC6HDAC1HDAC3HDAC5HDAC2
SCHEMBL17484068 0.83 HDAC1 (0.45) HDAC6HDAC1HDAC3HDAC5HDAC2
SCHEMBL17484025 0.83 ACHE (0.45) HDAC6HDAC1HDAC3HDAC5HDAC2
SCHEMBL19678427 0.80 HDAC6 (1.00) HDAC6HDAC1HDAC3HDAC5HDAC2
SCHEMBL16653780 0.80 HDAC6 (1.00) HDAC6HDAC1HDAC3HDAC5HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170349540-A1 HISTONE DEACETYLASE INHIBITORS THE GENERAL HOSPITAL CORPORATION 2017-12-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170349540-A1 HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC11, HDAC5 HDAC6 10/4885HDAC1 1/4885HDAC3 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback